🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
We are interested in whether bunionectomy can be used as a model to study t...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00601458
Treatments Being Tested
The purpose of this study is to determine the consistency of response for T...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-10
Trial ID
NCT00240617
Treatments Being Tested
LT-NS001 is a prodrug of Naproxen, which is inactive as a cox inhibitor whi...
Status
Completed
Location
Greystone Medical Research, LLC
Start Date
2010-02
Trial ID
NCT01063920
The study involves approximately 105 adolescent (ages 12-17) subjects to be...
Status
Completed
Location
Premiere Research Institute
Start Date
2010-03
Trial ID
NCT01016678
The purpose of this study is to evaluate the pain relieving effect and safe...
Status
Completed
Location
Multiple Locations
Start Date
2002-06-07
Trial ID
NCT00092729
Treatments Being Tested
Naxozol is a combination product of naproxen, a non-steroidal anti-inflamma...
Status
Unknown
Location
Hallym University Medical Center
Start Date
2015-02
Trial ID
NCT02355236
Treatments Being Tested
The purpose of this study is to compare naproxen plasma levels and gastrodu...
Status
Completed
Location
University of Illinois at Chicago
Start Date
2008-09
Trial ID
NCT00750243
A study to compare rofecoxib versus naproxen in the treatment of Chinese pa...
Status
Completed
Location
Multiple Locations
Start Date
2004-01-07
Trial ID
NCT00157872
Treatments Being Tested
We will evaluate the bioavailability of naproxen 500 mg administered as thr...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00665743
To study Celebrex versus naproxen to see if it decreases symptoms of juveni...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2002-10
Trial ID
NCT00652925